Logo
homeHome
toggle_offCompany ProfilegroupsBoards & Staffsworkspace_premiumMemberships & PartnersschoolAcademy of Journalismperson_addCareerslinkBlog(EN)emailContact Us
list_altOur JournalslightbulbInstruction for AuthorsbookmarkBrieflands PolicieshandshakePublish My Researchplay_circleJournal Management Systemcredit_cardArticle Processing Chargeszoom_inOpen Peer ReviewimagePublishing Services
menu_bookPublish My Book
  1. Brieflands
  2. journals
  3. Koomesh
  4. Articles

  5. Anti-proliferative effects of new synthesized hydrazone derivatives on breast, colon and hepatic cancer cells
  6. Scopus by Title (Ref)

Koomesh

Journal of Semnan University of Medical Sciences

homeHome
listAll Issuesplay_arrowIn Presscheck_circleAccepted ManuscriptssearchSearch
lightbulbInstructions
infoJournal InformationgroupsEditors & BoardspublicIndexing and Listing Sourcesquery_statsJournal Metricszoom_inOpen Peer Review (OPR)balancePublication Ethics and Publication Malpractice Statementassignment_indReviewer and AE Registration FormchatSupportphone_in_talkContact Us
euroAPC
Authors GuideSubmit Manuscript

Scopus by Title (Ref)


1. Synthesis, Antimicrobial Evaluation, Molecular Docking, and ADME Studies of Some Novel 3-Hydroxypyridine-4-one Derivatives

- Sadeghian S. , et al.

2. Effects of cold atmospheric plasma on viability of breast (MDA-MB-231) and cervical (Hela) cancer cells

- Jezeh M.A. , et al.

3. The effects of plasma-activated medium on the viability of breast (MDA-MB-231) and cervical (HeLa) cancer cell lines

- Aminraya-Jezeh M. , et al.

HomeInstructionsAPC

Articles

  • All Issues
  • In Press
  • Accepted Manuscripts
  • Search

About Journal

  • Journal Information
  • Editors & Boards
  • Indexing and Listing Sources
  • Journal Metrics
  • Open Peer Review (OPR)
  • Publication Ethics and Publication Malpractice Statement
  • Reviewer and AE Registration Form
  • Support
  • Contact Us
Support
Submit a Ticket
BrieflandsBrieflands

Science, Technical, Medical Publisher, Since 2007

All rights reserved by Brieflands, 2026.

Powered by Neoscriber.